Search Results for: Other roots with high insulin
subsidiary of novelion therapeutics inc., has agreed to plead guilty to charges relating to its prescription drug, juxtapid, the justice department announced today. as charged in a criminal information filed today, aegerion introduced juxtapid into interstate commerce that was misbranded because, among other
the district of massachusetts, the united states charged that, from december to december , aegerion introduced into interstate commerce juxtapid, a drug that was misbranded under the fdca. during this time period, juxtapid was approved by the u.s. food and drug administration (fda) to treat patients with...
https://www.justice.gov/opa/pr/drug-maker-aegerion-agrees-plead-guilty-will-pay-more-35-million-resolve-criminal-charges-and